Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC

Clinical trial NCT06553885 · RECRUITING

Trial details

NCT number: NCT06553885
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer Hepatocellular Carcinoma

Start date: 2025-04-01
Primary completion: 2029-09-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.